1-18 of 18
Takumi Shiraishi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4525: Cancer/testis antigens: A biomarker panel for prostate cancer screening

Luciane T. Kagohara, Prakash Kulkarni, Takumi Shiraishi, Robert Vessella, Robert W. Veltri, Elana J. Fertig
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4525.
https://doi.org/10.1158/1538-7445.AM2018-4525
Published: 01 July 2018
View article titled, Abstract 4525: Cancer/testis antigens: A biomarker panel for prostate cancer screening
Journal Articles

Abstract 4826: Cancer/testis antigen expression pattern is a potential biomarker for prostate cancer aggressiveness

Luciane T. Kagohara, Prakash Kulkarni, Takumi Shiraishi, Guangjing Zhu, Robert Vessella, Robert Veltri
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4826.
https://doi.org/10.1158/1538-7445.AM2015-4826
Published: 01 August 2015
View article titled, Abstract 4826: Cancer/testis antigen expression pattern is a potential biomarker for prostate cancer aggressiveness
Journal Articles

Abstract 1919: Profiling of cancer cell lines demonstrates a dynamic relationship between epithelial, mesenchymal and cancer stem states

James R. Hernandez, Steven M. Mooney, Takumi Shiraishi, James E. Verdone, Calvin A. Harberg, Donald Vindivich, Kenneth J. Pienta
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1919.
https://doi.org/10.1158/1538-7445.AM2014-1919
Published: 01 October 2014
View article titled, Abstract 1919: Profiling of cancer cell lines demonstrates a dynamic relationship between epithelial, mesenchymal and cancer stem states
Journal Articles

Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing

Yu Zeng, Dana Wodzenski, Dong Gao, Takumi Shiraishi, Naoki Terada, Youqiang Li, Donald J. Vander Griend, Jun Luo, Chuize Kong, Robert H. Getzenberg, Prakash Kulkarni
Journal: Cancer Research
Cancer Res (2013) 73 (13): 4123–4133.
https://doi.org/10.1158/0008-5472.CAN-12-1343
Published: 30 June 2013
View article titled, Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing
Open the PDF for Stress-Response Protein RBM3 Attenuates the Stem-like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing in another window
Includes: Supplementary data
Journal Articles

Abstract C44: The identification and characterization of androgen-independent cells prior to hormonal manipulation in prostate cancer

Naoki Terada, Takumi Shiraishi, Yu Zeng, Koh-Meng Aw-Yong, Steven M. Mooney, Jun Luo, Prakash Kulkarni, Robert H. Getzenberg
Journal: Cancer Research
Cancer Res (2012) 72 (4_Supplement): C44.
https://doi.org/10.1158/1538-7445.PRCA2012-C44
Published: 09 May 2013
View article titled, Abstract C44: The identification and characterization of androgen-independent cells prior to hormonal manipulation in prostate cancer
Journal Articles

Abstract 495: Overexpression of the cold-inducible RNA binding protein RBM3 attenuates the stem cell-like features of PC-3 cells

Yu Zeng, John Kim, Youqiang Li, Steven Mooney, Takumi Shiraishi, Prakash Kulkarni, Robert Getzenberg
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 495.
https://doi.org/10.1158/1538-7445.AM2011-495
Published: 15 April 2011
View article titled, Abstract 495: Overexpression of the cold-inducible RNA binding protein RBM3 attenuates the stem cell-like features of PC-3 cells
Journal Articles

Abstract #5499: Overcoming TRAIL resistance by dipyridamole: A new role for an old drug

Ahmed Goda, Tatsushi Yoshida, Mano Horinaka, Takashi Yasuda, Takumi Shiraishi, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5499.
Published: 01 May 2009
View article titled, Abstract #5499: Overcoming TRAIL resistance by dipyridamole: A new role for an old drug
Journal Articles

Upregulation of x-linked inhibitor of apoptosis protein expression in renal cell carcinoma and its prognostic significance

Yoichi Mizutani, Takashi Yasuda, Takumi Shiraishi, Terukazu Nakamura, Kazuya Mikami, Natsuki Takaha, Koji Okihara, Osamu Ukimura, Akihiro Kawauchi, Tsuneharu Miki
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2195.
Published: 01 May 2008
View article titled, Upregulation of x-linked inhibitor of apoptosis protein expression in renal cell carcinoma and its prognostic significance
Journal Articles

Enhanced orotate phosphoribosyltransferase activity in bladder cancer and its prognostic significance

Yoichi Mizutani, Taisuke Toiyama, Takumi Shiraishi, Terukazu Nakamura, Kazuya Mikami, Natsuki Takaha, Koji Okihara, Osamu Ukimura, Akihiro Kawauchi, Tsuneharu Miki
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 180.
Published: 01 May 2007
View article titled, Enhanced orotate phosphoribosyltransferase activity in bladder cancer and its prognostic significance
Journal Articles

Dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5134.
Published: 01 May 2007
View article titled, Dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
Journal Articles

Enhanced cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor.

Yoichi Mizutani, Yong Nan Li, Takumi Shiraishi, Terukazu Nakamura, Takeshi Nomoto, Koji Okihara, Osamu Ukimura, Kimihiko Yoneda, Akihiro Kawauchi, Tsuneharu Miki
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1272–1273.
Published: 15 April 2006
View article titled, Enhanced cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells <em>in vitro</em> and <em>in vivo</em> by the selective cyclooxygenase-2 inhibitor.
Journal Articles

Proteasome inhibitor MG132 induces Death Receptor 5 through CHOP in prostate cancer cell

Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 564.
Published: 15 April 2006
View article titled, Proteasome inhibitor MG132 induces Death Receptor 5 through CHOP in prostate cancer cell
Journal Articles

Luteolin induces death receptor 5 up-regulation and the combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Ryoko Nakanishi, Hoyoku Nishino, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 177.
Published: 15 April 2006
View article titled, Luteolin induces death receptor 5 up-regulation and the combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells
Journal Articles

Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells

Takumi Shiraishi, Tatsushi Yoshida, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (14): 6364–6370.
https://doi.org/10.1158/0008-5472.CAN-05-0312
Published: 15 July 2005
View article titled, Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells
Open the PDF for Tunicamycin Enhances Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Human Prostate Cancer Cells in another window
Journal Articles

Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein

Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5662–5667.
https://doi.org/10.1158/0008-5472.CAN-05-0693
Published: 01 July 2005
View article titled, Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein
Open the PDF for Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/Enhancer-Binding Protein Homologous Protein in another window
Journal Articles

Tunicamycin sensitizes TRAIL/Apo2L-induced apoptosis through up-regulation of death receptor 5/TRAIL-R2 in prostate cancer cells

Takumi Shiraishi, Tatsushi Yoshida, Susumu Nakata, Mano Horinaka, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 416.
Published: 01 May 2005
View article titled, Tunicamycin sensitizes TRAIL/Apo2L-induced apoptosis through up-regulation of death receptor 5/TRAIL-R2 in prostate cancer cells
Journal Articles

Significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase activity in renal cell carcinoma

Yoichi Mizutani, Hiroyuki Nakanishi, Takumi Shiraishi, Terukazu Nakamura, Takeshi Nomoto, Kazuya Mikami, Koji Okihara, Kimihiko Yoneda, Akihiro Kawauchi, Tsuneharu Miki
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 742.
Published: 01 May 2005
View article titled, Significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase activity in renal cell carcinoma
Journal Articles

Histone deacetylase inhibitors induce death receptor 5/TRAIL-R2, and potentiate TRAIL-mediated apoptosis in human malignant tumor cells

Susumu Nakata, Tatsushi Yoshida, Mano Horinaka, Takumi Shiraishi, Miki Wakada, Toshiyuki Sakai
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 413.
Published: 01 May 2005
View article titled, Histone deacetylase inhibitors induce death receptor 5/TRAIL-R2, and potentiate TRAIL-mediated apoptosis in human malignant tumor cells